全文获取类型
收费全文 | 69234篇 |
免费 | 6398篇 |
国内免费 | 5143篇 |
专业分类
耳鼻咽喉 | 400篇 |
儿科学 | 724篇 |
妇产科学 | 877篇 |
基础医学 | 8711篇 |
口腔科学 | 1185篇 |
临床医学 | 9336篇 |
内科学 | 10582篇 |
皮肤病学 | 774篇 |
神经病学 | 3645篇 |
特种医学 | 2438篇 |
外国民族医学 | 41篇 |
外科学 | 7072篇 |
综合类 | 11960篇 |
现状与发展 | 17篇 |
一般理论 | 2篇 |
预防医学 | 4259篇 |
眼科学 | 1827篇 |
药学 | 7406篇 |
74篇 | |
中国医学 | 3660篇 |
肿瘤学 | 5785篇 |
出版年
2024年 | 223篇 |
2023年 | 1194篇 |
2022年 | 2842篇 |
2021年 | 3572篇 |
2020年 | 2599篇 |
2019年 | 2357篇 |
2018年 | 2385篇 |
2017年 | 2046篇 |
2016年 | 2053篇 |
2015年 | 3134篇 |
2014年 | 3936篇 |
2013年 | 3271篇 |
2012年 | 4784篇 |
2011年 | 5664篇 |
2010年 | 3271篇 |
2009年 | 2486篇 |
2008年 | 3433篇 |
2007年 | 3572篇 |
2006年 | 3608篇 |
2005年 | 3462篇 |
2004年 | 2233篇 |
2003年 | 2197篇 |
2002年 | 1835篇 |
2001年 | 1693篇 |
2000年 | 1777篇 |
1999年 | 1972篇 |
1998年 | 1264篇 |
1997年 | 1365篇 |
1996年 | 1018篇 |
1995年 | 896篇 |
1994年 | 774篇 |
1993年 | 495篇 |
1992年 | 607篇 |
1991年 | 524篇 |
1990年 | 450篇 |
1989年 | 405篇 |
1988年 | 331篇 |
1987年 | 287篇 |
1986年 | 249篇 |
1985年 | 177篇 |
1984年 | 104篇 |
1983年 | 72篇 |
1982年 | 38篇 |
1981年 | 52篇 |
1980年 | 29篇 |
1979年 | 38篇 |
1963年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
ICAM-1 deficiency suppresses host allosensitization and rejection of MHC-disparate corneal transplants 总被引:6,自引:0,他引:6
BACKGROUND: We used a murine model of orthotopic corneal transplantation to determine whether host deficiency in ICAM-1 promotes survival of corneal grafts with different degrees of allodisparity. METHODS: ICAM-1-/- and wild-type C57BL/6 (ICAM-1+/+) received corneal grafts from the following strains of mice: BALB/c (fully mismatched), BALB.b (mismatched at multiple minor H only), or B10.D2 [including major histocompatibility complex (MHC) mismatch]. Graft rejection, induction of allospecific delayed-type hypersensitivity (DTH) responses, and leukocytic infiltration of grafts were measured. RESULTS: There were no differences in long-term survival of allografts that were either fully mismatched or had only minor H disparity in ICAM-1+/+ vs. ICAM-1-/-hosts. However, whereas B10.D2 grafts were accepted in only 58% of the ICAM-1+/+ hosts, graft survival in ICAM-1-/- recipients was 100% (P=0.006). Moreover, none of the ICAM-1-/- mice receiving B10.D2 grafts developed allospecific DTH. CONCLUSIONS: Prolonged survival seen in MHC-mismatched grafts in ICAM-1-/- mice, along with a suppressed DTH response to donor alloantigens after transplantation, suggest that ICAM-1 is associated with recipient sensitization to MHC alloantigens. 相似文献
992.
993.
994.
Zhu Wei-ping 《针灸推拿医学(英文版)》2003,1(6):24-25
Purpose: To observe the clinical therapeutic effect in the treatment of enuresis by ginger-partitioned moxibustion plus cupping therapy.Methods: Ginger-partitioned moxibustion was applied on Guanyuan (CV 4) and bilateral Zusanli (ST 36) and cupping therapy was applied
on Shenque (CV 8) in the treatment of 82 cases of enuresis, in comparison with 76 cases treated by Chinese herbal medicine.Results: The effective rate was 84.1% in the treatment by ginger-partitioned moxibustion plus cupping therapy and was 64.5% in the
treatment by Chinese herbal medicine.Conclusion: Ginger-partitioned moxibustion plus cupping therapy was better than Chinese herbal medicine in the treatment of enuresis
(P<0.05).
Translator: HUANG Guo-qi 相似文献
995.
996.
997.
Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. 总被引:27,自引:0,他引:27
Donghui Li Jijiang Zhu Pervez F Firozi James L Abbruzzese Douglas B Evans Karen Cleary Helmut Friess Subrata Sen 《Clinical cancer research》2003,9(3):991-997
PURPOSE: Multiple chromosome abnormalities, including gain of chromosome20q, have been detected frequently in human pancreatic cancers. Overexpression of the STK15/BTAK/Aurora A gene located on chromosome 20q13, which encodes a centrosome-associated serine/threonine kinase, has been shown to induce chromosomal instability, leading to aneuploidy and cell transformation in multiple in vitro experimental systems. The purpose of this study was to investigate the expression and copy number alteration of STK15 in pancreatic cancer. EXPERIMENTAL DESIGN: STK15 expression at both the mRNA and protein levels together with the copy number of STK15 gene was measured in nine pancreatic carcinoma cell lines: (a) HPAF-II; (b) Aspc-1; (c) Panc-1; (d) Panc-3; (e) Panc-28; (f) Panc-48; (g) HS766T; (h) MIAPaCa-2; and (i) BxPc3. STK15 protein expression was also examined in normal pancreatic tissues and tumors by Western blotting and immunohistochemistry. RESULTS: STK15 was overexpressed in all of the nine cell lines examined, but gene amplification was infrequent. Western Blot analysis of primary tumor tissues revealed 2-10 times overexpression of STK15 protein compared with normal adjacent tissues from pancreatic cancer patients. Concurrent overexpression of cdc20, an STK15-associated protein, and reduced expression of cdc25, a mitosis-activating protein phosphatase, were detected in the same tumor samples. Elevated STK15 protein expression was detected in 22 of 38 tumor sections (58%) from pancreatic cancer patients. The extent of STK15 expression was not significantly correlated with the size, degree of differentiation, and metastasis status of the tumors. CONCLUSIONS: These results show that STK15 is overexpressed in pancreatic tumors and carcinoma cell lines and suggest that overexpression of STK15 may play a role in pancreatic carcinogenesis. 相似文献
998.
目的 为了特异封闭白血病细胞survivin的表达,抑制其功能,本实验构建了survivin反义核酸载体并导入白血病细胞系中。方法 应用RT—PCR获得survivin的cDNA片段,反向插入pcDNA3质粒载体中;经限制性酶切和测序鉴定所构建的反义核酸是否正确;采用电转染方法将重组体导入HL—60细胞中;RT—PCR技术检测转染细胞survivin表达的变化。结果 经限制性酶切和测序鉴定证明survivin反义核酸已成功构建;RT—PCR产物电泳结果显示,与转染前细胞、空质粒转染细胞相比,转染survivin反义核酸的细胞survivin mRNA水平明显降低。结论 本实验已成功建立了survivin反义核酸真核表达载体,而且在白血病细胞系中发挥了特异封闭作用,为进一步研究survivin反义核酸在白血病治疗中的作用提供了实验基础。 相似文献
999.
Z Zhu K Hattori H Zhang X Jimenez D L Ludwig S Dias P Kussie H Koo H J Kim D Lu M Liu R Tejada M Friedrich P Bohlen L Witte S Rafii 《Leukemia》2003,17(3):604-611
Vascular endothelial growth factor (VEGF) and its receptors (VEGFR) have been implicated in promoting solid tumor growth and metastasis via stimulating tumor-associated angiogenesis. We recently showed that certain 'liquid' tumors such as leukemia not only produce VEGF, but also express functional VEGFR, resulting in an autocrine loop for tumor growth and propagation. A chimeric anti-VEGFR2 (or kinase insert domain-containing receptor, KDR) antibody, IMC-1C11, was shown to be able to inhibit VEGF-induced proliferation of human leukemia cells in vitro, and to prolong survival of nonobese diabetic-severe combined immune deficient (NOD-SCID) mice inoculated with human leukemia cells. Here we produced two fully human anti-KDR antibodies (IgG1), IMC-2C6 and IMC-1121, from Fab fragments originally isolated from a large antibody phage display library. These antibodies bind specifically to KDR with high affinities: 50 and 200 pM for IMC-1121 and IMC-2C6, respectively, as compared to 270 pM for IMC-1C11. Like IMC-1C11, both human antibodies block VEGF/KDR interaction with an IC(50) of approximately 1 nM, but IMC-1121 is a more potent inhibitor to VEGF-stimulated proliferation of human endothelial cells. These anti-KDR antibodies strongly inhibited VEGF-induced migration of human leukemia cells in vitro, and when administered in vivo, significantly prolonged survival of NOD-SCID mice inoculated with human leukemia cells. It is noteworthy that the mice treated with antibody of the highest affinity, IMC-1121, survived the longest period of time, followed by mice treated with IMC-2C6 and IMC-1C11. Taken together, our data suggest that anti-KDR antibodies may have broad applications in the treatment of both solid tumors and leukemia. It further underscores the efforts to identify antibodies of high affinity for enhanced antiangiogenic and antitumor activities. 相似文献
1000.